Acute Kidney Disease
18
2
2
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
2 terminated out of 18 trials
81.8%
-4.7% vs benchmark
6%
1 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (18)
Predicting Post-Cardiac Surgery Acute Kidney Disease: A Machine Learning Approach
Incidence and Prognostic of Cardiac Surgery-Associated Acute Kidney Injury: A Spanish Multicenter Study (SCARS-AKI)
Prospective Validation of Machine Learning Model to Predict Platinum Induced Nephrotoxicity in Cancer Patients
Evaluation of Clinical Pharmacy Services and Drug Use in Renal Impairment.
Trimethoprim-Sulfamethoxazole (TMP/SMX) Prophylaxis After Acute Kidney Injury to Prevent Post-discharge Infections
AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney Disease
The Effect of Preoperative Biological Age on Hemodynamics and Renal Function
Impact of Different CRRT Modalities, Dosing Strategies, and Timing on Kidney Recovery and Prolonged Kidney Dysfunction
Perioperative Nitric Oxide Prevents Acute Kidney Injury in Cardiac Surgery Patients With Chronic Kidney Disease
Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum
A Clinical Diagnostic System for Intrinsic Acute Kidney Disease
Preoperative RRI and Long-term Risk for CKD
Effect of CVP and IOH on AKI and AKD
Shear Wave Elastography in Native Kidney Disease
Intensified Acute Kidney Disease Care to Reduce Chronic Kidney Disease
Renal Outcome of Acute Kidney Disease
Evaluating the Role of Cystatin C and Creatinine as Markers of Renal Recovery in Critically Ill Patients After Acute Kidney Injury.
Intraoperative Dialysis in Liver Transplantation